

Cover Story
Free
By Alexandria Carolan
A sense of foreboding descended on Narjust Duma as she sat at a presentation on drug-induced toxicities. The year was 2018, Duma was a 31-year-old second-year fellow at Mayo Clinic, and her discomfort stemmed from something other than the subject matter discussed.
In Brief


Clinical Roundup
Drugs & Targets
Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned














